Institut DERMed Clinical Skin Care

Products          Training          Spa

Sign InMy AccountCustomer ServiceShopping Cart

Distribution: 1-866-433-7633
Spa: 404-261-5199

Tuesday, 30 August 2011 17:45

Institut Dermed Introduces New Chromabright Serum

Rate this item
(0 votes)

Chromabright headr 1

 

 


 

Chemist’s Clinical Ingredient Research

 

Introducing...

CHROMABRIGHT™

A CUTTING-EDGE MOLECULE
FOR A RADIANT SKIN TONE
and a new active for safe
skin brightening


Chromabright chart img 
CHROMABRIGHT™, a new patented molecule for skin brightening:
 
    • Inhibits human tyrosinase activity in vitro

    • Higher melanogenesis inhibition than Arbutin, MAP and Kojic Acid

    • Same depigmenting activity than Hydroquinone without cytotoxicity

    • Proven in vivo brightening efficacy

    • High stability in formulations

    • High solubility in oils

  • Impeccable safety profile
 

Primary human melanocytes (hemn-dp) cell cultures were used to compare the skin lightening performance of Hydroquinone, Arbutin, Magnesium Ascorbyl Phosphate (MAP) and Kojic Acid to that of CHROMABRIGHT™ at the same concentration (10μM) for a period of 20 days. As the graph above demonstrates, CHROMABRIGHT™ exhibited a better depigmenting effect than MAP, Kojic Acid and Arbutin, and a had similar efficacy to Hydroquonone.

 
  • Unlike other depigmenting agents that can cause photo irritation, preventing UV-induced skin damage, CHROMABRIGHT™ has a photoprotective effect.